VCM
NVAX icon

Voleon Capital Management’s Novavax NVAX Stock Holding History

Voleon Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Sell
32,112
-91,443
-74% -$819K 0.01% 679
2026
Q1 		$1.01M Buy
123,555
+4,803
+4% +$43.5K 0.02% 439
2025
Q4 		$798K Buy
+118,752
New +$895K 0.02% 482

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Voleon Capital Management's NVAX Position: Q2 2026 in Review

Voleon Capital Management reduced its Novavax (NVAX) stake by 74% in Q2 2026, selling an estimated $819K and leaving 32,112 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #679.

Voleon Capital Management first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.01M in Q1 2026. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Voleon Capital Management held 32,112 shares of Novavax worth $302K as of Q2 2026.
  • Voleon Capital Management sold 91,443 Novavax shares in Q2 2026, an estimated $819K.
  • Novavax made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #679 holding.
  • Voleon Capital Management first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
  • Voleon Capital Management's Novavax position peaked at $1.01M in Q1 2026.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.